NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-146-1992-0-US-23 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY US FWC 08/330,865 6040334 Expired PDF
NIAID E-123-1992-2-NZ-10 ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS NZ National Stage 252857 Expired
NHLBI E-151-1993-0-US-02 TARGETABLE VECTOR PARTICLES US FWC 08/326,347 Abandoned
NHLBI E-152-1993-0-US-07 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM US FWC 08/326,348 Abandoned
NCI E-029-1990-1-US-02 HEPATOCELLULAR CARCINOMA ONCOGENE US FWC 08/324,445 5811262 Abandoned PDF
NINDS E-018-1995-0-US-01 METHOD OF MAKING PERCUTANEOUS CONNECOTR FOR MULT-CONDUCTOR ELECTRICAL CABLES US ORD 08/326,291 5604976 Abandoned PDF
NICHD E-177-1990-3-US-01 NEUROTROPHIC PEPTIDES OF ACTIVITY DEPENDENT NEUROTROPHIC FACTOR (as filed) US CIP 08/324,297 6174862 Expired PDF
NINDS E-530-1986-1-US-06 IMMUNOTOXINS - MUTANT DIPHTHERIA TOXIN CONJUGATES US CON 08/323,591 5792458 Expired PDF
NICHD E-202-1994-0-US-01 Synthesis of a Typhoid Fever Vaccine From a Plant or a Fruit Polysaccharide US ORD 08/323,918 5738855 Expired PDF
NIAID E-072-1993-0-US-03 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, PFS230 US FWC 08/323,170 5733772 Abandoned PDF
NHLBI E-143-1993-0-PCT-02 SELECTIVE ADENOVIRAL-MEDIATED GENE TRANSFER INTO VASCULAR NEOINTIMA PCT PCT PCT/US1994/011676 Expired
NIAID E-220-1989-2-US-03 PRODUCTION OF ISOLATED PROTEINACEOUS MATERIALS USING RECOMBINANT AVIPOX VIRUS VECTORS US CON 08/322,358 Abandoned
NCI E-221-1993-3-EP-23 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders EP DIV 04030912.2 Abandoned
NCI E-221-1993-3-ES-38 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders ES EP 04030912.2 Abandoned
NCI E-221-1993-3-PT-57 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders PT EP 04030912.2 Abandoned
NCI E-221-1993-3-RS-59 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders RS EP 04030912.2 Abandoned
NCI E-221-1993-3-SI-61 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders SI EP 04030912.2 Abandoned
NCI E-221-1993-3-MC-52 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders MC EP 04030912.2 Abandoned
NCI E-221-1993-3-SK-62 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders SK EP 04030912.2 Abandoned
NCI E-221-1993-3-NL-55 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders NL EP 04030912.2 Abandoned
NCI E-221-1993-3-RO-58 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders RO EP 04030912.2 Abandoned
NCI E-221-1993-3-MK-53 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders MK EP 04030912.2 Abandoned
NCI E-221-1993-3-PL-56 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders PL EP 04030912.2 Abandoned
NCI E-221-1993-3-FR-40 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders FR EP 04030912.2 Abandoned
NCI E-221-1993-3-FI-39 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders FI EP 04030912.2 Abandoned
NCI E-221-1993-3-DE-35 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders DE EP 04030912.2 Abandoned
NCI E-221-1993-3-EE-37 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders EE EP 04030912.2 Abandoned
NCI E-221-1993-3-LU-50 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LU EP 04030912.2 Abandoned
NCI E-221-1993-3-LT-49 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LT EP 04030912.2 Abandoned
NCI E-221-1993-3-MT-54 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders MT EP 04030912.2 Abandoned
NCI E-221-1993-3-LV-51 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LV EP 04030912.2 Abandoned
NCI E-221-1993-3-LI-48 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LI EP 04030912.2 Abandoned
NCI E-221-1993-3-AT-28 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AT EP 04030912.2 Abandoned
NCI E-221-1993-3-BE-30 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BE EP 04030912.2 Abandoned
NCI E-221-1993-3-AL-27 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AL EP 04030912.2 Abandoned
NCI E-221-1993-3-CZ-34 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CZ EP 04030912.2 Abandoned
NCI E-221-1993-3-CY-33 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CY EP 04030912.2 Abandoned
NCI E-221-1993-3-DK-36 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders DK EP 04030912.2 Abandoned
NCI E-221-1993-3-BG-31 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BG EP 04030912.2 Abandoned
NCI E-221-1993-3-HR-43 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders HR EP 04030912.2 Abandoned
NCI E-221-1993-3-GB-41 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders GB EP 04030912.2 Abandoned
NCI E-221-1993-3-SE-60 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders SE EP 04030912.2 Abandoned
NCI E-221-1993-3-CH-32 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CH EP 04030912.2 Abandoned
NCI E-221-1993-3-TR-63 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders TR EP 04030912.2 Abandoned
NCI E-221-1993-3-IT-47 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IT EP 04030912.2 Abandoned
NCI E-221-1993-3-HU-44 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders HU EP 04030912.2 Abandoned
NCI E-221-1993-3-IE-45 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disordersz IE EP 04030912.2 Abandoned
NCI E-221-1993-3-IS-46 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IS EP 04030912.2 Abandoned
NCI E-221-1993-3-GR-42 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders GR EP 04030912.2 Abandoned
NCI E-221-1993-3-CA-09 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CA National Stage 2173976 Abandoned